Polar Capital LLP - AERIE PHARMACEUTICALS INC ownership

AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
Polar Capital LLP ownership history of AERIE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$3,610,000
-53.1%
100,000
-20.0%
0.04%
-40.0%
Q3 2018$7,694,000
+51.9%
125,000
+66.7%
0.06%
+109.7%
Q2 2018$5,066,000
+211.2%
75,000
+150.0%
0.03%
+93.8%
Q1 2018$1,628,000
-72.8%
30,000
-70.0%
0.02%
-74.2%
Q4 2017$5,975,000
+836.5%
100,000
+176.8%
0.06%
+416.7%
Q2 2015$638,000
-4.5%
36,130
+69.5%
0.01%
-7.7%
Q1 2015$668,000
-10.0%
21,310
-16.1%
0.01%
-7.1%
Q4 2014$742,000
+115.7%
25,407
+52.9%
0.01%
+100.0%
Q3 2014$344,00016,6130.01%
Other shareholders
AERIE PHARMACEUTICALS INC shareholders Q1 2018
NameSharesValueWeighting ↓
LEVIN CAPITAL STRATEGIES, L.P. 1,373,542$15,658,0001.56%
DAFNA Capital Management LLC 289,040$3,295,0000.87%
Integral Health Asset Management, LLC 250,000$2,850,0000.82%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 193,266$2,203,0000.80%
PFM Health Sciences, LP 2,182,684$24,883,0000.73%
DCF Advisers, LLC 136,501$1,556,0000.69%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,977,020$33,938,0000.66%
NEXPOINT ASSET MANAGEMENT, L.P. 309,778$3,532,0000.61%
Rhenman & Partners Asset Management AB 750,000$8,550,0000.60%
RICE HALL JAMES & ASSOCIATES, LLC 1,232,600$14,052,0000.52%
View complete list of AERIE PHARMACEUTICALS INC shareholders